查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1715639

心血管設備市場：按設備類型、操作類型、存取類型、應用程式和最終用戶 - 2025-2030 年全球預測

Cardiovascular Devices Market by Device Type, Operation Type, Access Type, Application, End User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 186 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計 2024 年心血管設備市場價值將達到 592.1 億美元，2025 年將成長至 637.7 億美元，複合年成長率為 7.82%，到 2030 年將達到 930.4 億美元。

主要市場統計數據
基準年2024年 592.1億美元
預計2025年 637.7億美元
預測年份 2030 930.4億美元
複合年成長率（%） 7.82%

心血管設備市場始終處於醫療創新的前沿，透過最尖端科技與紮實臨床洞察力的結合不斷提高護理標準。慢性心血管疾病仍然是全球發病率和死亡率的重要原因，因此業界對提高診斷準確性、簡化手術介入和提供有效治療方案的系統的需求正在迅速成長。本概述揭示了催化這些市場趨勢的因素，強調了技術進步、不斷發展的法律規範以及日益成長的個人化治療策略需求之間的相互作用。該領域融合了臨床專業知識和工程智慧，其重要性日益增加，共同塑造了以改善患者治療結果和簡化程序為醫療實踐核心的未來。

在動態生態系統的支持下，從設備製造商到醫療保健從業者的相關人員正在積極為充滿希望但又充滿挑戰的領域做出貢獻。新材料的引入、設備的數位整合以及先進數據分析的採用推動了市場轉型。這些因素不僅機會，也為挑戰現有範式的變革提供了機會。該分析不僅闡明了市場的現狀，而且還預測了由不斷創新和戰略遠見驅動的潛在發展軌跡。

顛覆性創新與市場里程碑塑造心血管設備

近年來，心血管設備市場發生了重大變化，重新定義了行業標準並帶來了前所未有的臨床效益。一系列創造性創新正在改變這一格局，包括智慧感測器技術的整合、設備組件的小型化以及擴大使用無線連接來遠端監控患者數據。這些突破性的創新對於提高操作可靠性和患者舒適度至關重要，並繼續重新定義設備功能和設計的可能性。

先進的影像技術和電腦輔助介入系統提高了診斷程序和手術干預的精確度。這些技術不僅降低了手術風險，而且還使醫生能夠更準確地做出數據主導的決策。人工智慧和機器學習的採用將進一步支持心血管數據的分析，從而能夠更早發現異常並提供有助於患者護理的預測性見解。同時，從傳統笨重的設備向更緊湊、更高效的系統的轉變凸顯了該行業致力於在不犧牲性能的情況下最佳化用戶便利性的承諾。

隨著報銷策略的不斷演變和對長期患者治療效果的日益重視，該行業的投資興趣正在重新運作。突破性產品的推出和增強的製造通訊協定正在縮短產品上市時間，形成有利於具有敏捷研發能力的公司的競爭格局。這樣，市場不僅反映了對當前醫療需求的回應，也為科技進步推動的未來趨勢奠定了基礎。

詳細的市場區隔以推動策略成果

細緻地了解市場細分對於駕馭多方面的心血管設備領域至關重要。市場分析基於多個維度，可提供新商業機會的詳細視圖。關鍵的細分是根據設備的類型，分析重點放在三個主要類別：診斷和監測設備、手術設備和治療設備。在診斷及監測設備領域，涵蓋心電圖系統、電極導線及配件、心臟事件記錄器、心電圖監測、植入式動態心電圖監測儀等關鍵設備。同時，外科手術器械領域深入研究心臟支架、導管、心臟瓣膜和血管移植的複雜性。另一方面，治療設備的特點是血壓計、心臟去顫器和心律調節器等特定設備在穩定患者病情和預防危及生命的緊急情況方面發揮著至關重要的作用。

細分的另一個方面是基於手術類型，將設備分為侵入性和非侵入性類別。這種分類不僅有助於理解程序的複雜性，還可以幫助了解不同臨床環境中的不同採用率。此外，基於存取類型的細分將市場分為經皮和經靜脈方法，反映了程序途徑如何影響設備設計和病患管理策略。值得注意的是，心血管設備在臨床適應症的應用是關鍵因素。市場分析擴展到包括心律管理、冠狀動脈疾病、周邊血管疾病和中風管理的應用。每個應用領域都需要特定的治療和診斷能力，最終推動產品客製化和創新。

最後，市場按最終用戶進行細分，重點關注門診手術中心、居家醫療以及醫院和診所等各種環境。這種細分框架不僅提供了對利用模式的更好理解，而且還強調了醫療保健基礎設施之間的不同業務重點。協同效應，這些細分策略為識別關鍵市場促進因素和提供更能滿足不同患者群體和臨床環境需求的產品提供了一個基本架構。

目錄

第1章 引言

第2章調查方法

第3章執行摘要

第4章 市場概述

第5章 市場洞察

  • 市場動態
    • 驅動程式
      • 人群中心血管疾病的盛行率不斷上升
      • 擴大全球醫療基礎設施
    • 限制因素
      • 心血管設備召回率問題
    • 機會
      • 家庭醫療保健中心血管設備的採用率不斷提高
      • 政府措施和資金推動心血管設備普及
    • 任務
      • 設備核准流程的嚴格監管要求
  • 市場區隔分析
    • 設備類型：血壓監測儀是診斷和管理高血壓的必備設備，其普及率正在激增
    • 最終使用者：門診手術中心心血管設備的使用發展
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社會
    • 技術的
    • 合法的
    • 環境

6. 心血管設備市場（依設備類型）

  • 診斷和監測設備
    • 心電圖系統
    • 電極導線及配件
    • 心臟事件記錄器
    • 心電圖監測
    • 嵌入式循環錄音機
  • 手術設備
    • 心臟支架
    • 導管
    • 心臟瓣膜
    • 血管移植物
  • 處理設備
    • 血壓計
    • 心臟去顫器
    • 心律調節器

第7章心血管設備市場運作類型）

  • 侵入性設備
  • 非侵入式設備

8. 心血管設備市場進入類型）

  • 經皮
  • 靜脈

9. 心血管設備市場（依應用）

  • 心律管理
  • 冠狀動脈疾病
  • 周邊血管疾病
  • 中風管理

第 10 章心血管設備市場（按最終用戶分類）

  • 門診手術中心
  • 居家護理
  • 醫院和診所

第 11 章：美洲心血管設備市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

12.亞太心血管設備市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

13. 歐洲、中東和非洲心血管設備市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第14章競爭格局

  • 2024年市場佔有率分析
  • 2024年FPNV定位矩陣
  • 競爭情境分析
  • 戰略分析與建議

公司名單

  • Abbott Laboratories
  • ACS Diagnostics
  • Alivecor, Inc.
  • Asahi Kasei Corporation
  • B. Braun SE
  • Baxter International Inc.
  • Bexen Medical
  • Biotronik SE & Co KG
  • Boston Scientific Corporation
  • BPL Medical Technologies Private Limited
  • Edwards Lifesciences Corporation
  • GE Healthcare
  • HeartFlow Holding, Inc.
  • Johnson & Johnson Services, Inc.
  • Koninklijke Philips NV,
  • Lepu Medical Technology（Beijing）Co.,Ltd.
  • LivaNova PLC
  • Medtronic PLC
  • Microport Scientific Corporation
  • Nihon Kohden Corporation
  • Schiller AG
  • Siemens Healthineers
  • Terumo Cardiovascular Systems Corporation
  • Tricog Health
  • Vesalius Cardiovascular Inc.
  • Zoll Medical Corporation
Product Code: MRR-D2073C5D8E6E

The Cardiovascular Devices Market was valued at USD 59.21 billion in 2024 and is projected to grow to USD 63.77 billion in 2025, with a CAGR of 7.82%, reaching USD 93.04 billion by 2030.

KEY MARKET STATISTICS
Base Year [2024] USD 59.21 billion
Estimated Year [2025] USD 63.77 billion
Forecast Year [2030] USD 93.04 billion
CAGR (%) 7.82%

The cardiovascular devices market continues to be at the forefront of medical innovation, consistently advancing the standard of care through a blend of cutting-edge technology and robust clinical insight. In an era where chronic cardiovascular conditions remain a significant contributor to global morbidity and mortality, the industry is witnessing a compelling increase in demand for systems designed to enhance diagnostic precision, streamline surgical intervention, and provide effective therapeutic solutions. This introductory overview unpacks the factors catalyzing these market trends, emphasizing the interplay between technological breakthroughs, evolving regulatory frameworks, and the increasing need for personalized treatment strategies. The sector's growing importance is underscored by the convergence of clinical expertise and engineering ingenuity, which together are shaping a future where improved patient outcomes and streamlined procedures are at the core of medical practice.

Underpinned by a dynamic ecosystem, stakeholders ranging from device manufacturers to healthcare practitioners are actively contributing to a landscape that is as challenging as it is promising. The market's transformation is driven by an infusion of novel materials, digital integration in devices, and the adaptation of advanced data analytics. These elements coalesce to offer not only incremental enhancements to existing solutions but also transformative opportunities that challenge existing paradigms. As we delve deeper into the subsequent sections, this analysis will illuminate not only the current state of the market but also forecast potential trajectories fueled by continuous innovation and strategic foresight.

Disruptive Innovations and Market Milestones Shaping Cardiovascular Devices

Recent years have witnessed profound shifts in the cardiovascular devices market that have redefined industry standards and delivered unprecedented clinical benefits. The landscape is being transformed by a series of disruptive innovations, including the integration of smart sensor technology, miniaturization of device components, and the increasing use of wireless connectivity to monitor patient data remotely. These breakthroughs have been pivotal in enhancing operational reliability and patient comfort, and they continue to redefine the possibilities for both device functionality and design.

Advanced imaging techniques and computer-assisted intervention systems are adding layers of precision to diagnostic procedures and surgical interventions. Such technology not only lowers procedural risks but also supports physicians in making data-driven decisions with heightened accuracy. The adoption of artificial intelligence and machine learning further supports the analysis of cardiovascular data, enabling early detection of anomalies and offering predictive insights that inform patient care. Meanwhile, the transition from traditional, cumbersome devices to more compact, efficient systems highlights the sector's commitment to optimizing user convenience without sacrificing performance.

With evolving reimbursement strategies and an increasing focus on long-term patient outcomes, the industry is witnessing a reinvigoration of investment interest. Breakthrough product launches and enhanced manufacturing protocols have accelerated time-to-market, catalyzing a competitive landscape that favors those with agile research and development capabilities. As such, the market not only reflects a response to current medical needs but also sets the stage for future trends driven by scientific and technological advancements.

Detailed Market Segmentation Driving Strategic Outcomes

In navigating the multifaceted landscape of cardiovascular devices, a nuanced understanding of market segmentation is crucial. The market is analyzed based on several dimensions that collectively provide a granular view of emerging opportunities. An important segmentation is according to device type, where the analysis focuses on three key categories: Diagnostic & Monitoring Devices, Surgical Devices, and Therapeutic Devices. Within the diagnostic and monitoring sphere, the investigation extends to encompass critical instruments such as ECG systems, electrode leads and accessories, event monitors, Holter monitors, and implantable loop recorders. In parallel, the surgical devices segment delves into the intricacies of cardiac stents, catheters, heart valves, and vascular grafts, each engineered to address distinct aspects of cardiovascular intervention. Meanwhile, the therapeutic devices are characterized by specific instruments including blood pressure monitors, defibrillators, and pacemakers, which play a pivotal role in stabilizing patient conditions and preventing life-threatening emergencies.

A further dimension of segmentation is based on the type of operation, where devices are classified into invasive and non-invasive categories. This classification not only helps in understanding the procedural complexity but also offers insights into varying adoption rates across different clinical environments. Additionally, segmentation based on access type divides the market into transcutaneous and transvenous approaches, reflecting how procedural pathways influence device design and patient management strategies. Notably, the application of cardiovascular devices into clinical conditions is a defining element; the market analysis is broadened to include applications in cardiac rhythm management, coronary artery disease, peripheral vascular disease, and stroke management. Each of these application areas demands specific therapeutic and diagnostic capabilities that ultimately drive product customization and innovation.

Finally, the market is segmented by end user, with a focus on diverse settings such as ambulatory surgical centers, home care, and hospitals and clinics. This segmentation framework not only enhances our understanding of usage patterns but also highlights the varying operational priorities across healthcare infrastructures. The synergy of these segmentation strategies provides a framework that is indispensable for identifying key market drivers and tailoring product offerings to meet the precise needs of different patient populations and clinical environments.

Based on Device Type, market is studied across Diagnostic & Monitoring Devices, Surgical Devices, and Therapeutic Devices. The Diagnostic & Monitoring Devices is further studied across ECG Systems, Electrode Leads & Accessories, Event Monitors, Holter Monitors, and Implantable Loop Recorders. The Surgical Devices is further studied across Cardiac Stents, Catheters, Heart Valves, and Vascular Grafts. The Therapeutic Devices is further studied across Blood Pressure Monitors, Defibrillators, and Pacemakers.

Based on Operation Type, market is studied across Invasive Devices and Non-Invasive Devices.

Based on Access Type, market is studied across Transcutaneous and Transvenous.

Based on Application, market is studied across Cardiac Rhythm Management, Coronary Artery Disease, Peripheral Vascular Disease, and Stroke Management.

Based on End User, market is studied across Ambulatory Surgical Centers, Home Care, and Hospitals & Clinics.

Regional Overview Unlocking Global Market Opportunities

When examining the geographical distribution of the cardiovascular devices market, distinct regional nuances emerge, each contributing uniquely to the overall global picture. In the Americas, robust regulatory frameworks paired with high healthcare spending have paved the way for rapid adoption of innovative device technologies. This region benefits from a synergy of well-established clinical infrastructures and a proactive approach toward integrating next-generation diagnostic and therapeutic solutions. The MAJOR markets here are often characterized by a mature technology landscape combined with significant investments in research and development, which in turn ensure a steady influx of state-of-the-art devices.

Moving to the Europe, Middle East & Africa region, the market is marked by a combination of established healthcare systems and emerging economies that are progressively upgrading their clinical capabilities. This region displays a blend of rigorous quality standards and a focus on patient-centric care, which drives both innovation and cautious regulatory oversight. Advanced healthcare economies in this grouping are adapting quickly to the digital transformation of medical devices, while emerging markets are keen on adopting scalable, cost-effective solutions that enhance clinical outcomes.

In the Asia-Pacific region, the landscape is particularly dynamic with rapid urbanization, increasing healthcare expenditure, and a progressive shift towards advanced treatment options. Here, a burgeoning middle class and significant investments in healthcare infrastructure are creating fertile ground for both established and emerging device manufacturers. Insights from this region reveal an accelerating pace of technology adoption and high growth potential driven by large patient populations and the expansion of health awareness initiatives. Overall, these regional insights demonstrate the necessity for market strategies to be tailored to diverse regulatory environments, consumer behaviors, and economic conditions across these global markets.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

Leading Industry Players Driving Market Innovation

The competitive landscape in the cardiovascular devices realm is defined by the leadership of companies that consistently push the boundaries of what is medically possible. Major players have not only demonstrated resilience in the face of evolving regulatory requirements and technological shifts but have also spearheaded groundbreaking innovations that are setting new benchmarks in patient care. Among these leaders are globally recognized entities such as Abbott Laboratories, ACS Diagnostics, and Alivecor, Inc., who are renowned for their technological prowess and strategic market positioning. In addition, companies like Asahi Kasei Corporation and B. Braun SE have leveraged deep clinical expertise and advanced engineering capabilities to develop sophisticated devices that cater to specialized clinical needs.

Other influential market participants include Baxter International Inc. and Bexen Medical, both of which are heralded for their commitment to quality and ongoing research and development. Companies like Biotronik SE & Co KG and Boston Scientific Corporation are at the forefront of integrating digital innovation with patient care, further solidifying their market foothold through a blend of innovation and clinical efficacy. Additionally, the contributions of BPL Medical Technologies Private Limited and Edwards Lifesciences Corporation exemplify how strategic investments in device technology can drive significant clinical and operational improvements. Major names in the realm of holistic cardiovascular solutions, such as GE Healthcare and HeartFlow Holding, Inc., add further depth to the competitive narrative by harnessing data analytics and imaging breakthroughs.

Market leaders including Johnson & Johnson Services, Inc., Koninklijke Philips N.V., and Lepu Medical Technology(Beijing)Co.,Ltd. have also carved out significant niches, offering diversified portfolios that cater to a wide array of cardiovascular conditions. Meanwhile, all-encompassing innovators like LivaNova PLC, Medtronic PLC, and Microport Scientific Corporation continue to set industry trends with products built on the foundation of rigorous clinical validation and forward-thinking design. The landscape is further enriched by the presence of Nihon Kohden Corporation, Schiller AG, Siemens Healthineers, and Terumo Cardiovascular Systems Corporation, who exemplify how synergistic partnerships between technology and healthcare can revolutionize treatment modalities. Finally, trailblazing companies such as Tricog Health, Vesalius Cardiovascular Inc., and Zoll Medical Corporation illustrate the market's commitment to continuous improvement and state-of-the-art clinical interventions, making the competitive arena as dynamic as it is innovative.

The report delves into recent significant developments in the Cardiovascular Devices Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, ACS Diagnostics, Alivecor, Inc., Asahi Kasei Corporation, B. Braun SE, Baxter International Inc., Bexen Medical, Biotronik SE & Co KG, Boston Scientific Corporation, BPL Medical Technologies Private Limited, Edwards Lifesciences Corporation, GE Healthcare, HeartFlow Holding, Inc., Johnson & Johnson Services, Inc., Koninklijke Philips N.V.,, Lepu Medical Technology(Beijing)Co.,Ltd., LivaNova PLC, Medtronic PLC, Microport Scientific Corporation, Nihon Kohden Corporation, Schiller AG, Siemens Healthineers, Terumo Cardiovascular Systems Corporation, Tricog Health, Vesalius Cardiovascular Inc., and Zoll Medical Corporation. Strategic Roadmap for Capturing Emerging Opportunities

Industry leaders are encouraged to approach the cardiovascular devices market with a strategic mindset that balances innovation with market pragmatism. One actionable recommendation is to deepen engagement with emerging technologies that usher in efficiency gains and enhanced patient experiences. Investment in areas such as artificial intelligence, advanced data analytics, and digital health platforms is essential. Leveraging these innovations will not only speed up the innovation cycle but also improve diagnostic accuracy and operational efficiencies.

It is imperative for companies to invest in robust post-market surveillance programs that can provide ongoing insights into device performance. This not only reassures regulators and healthcare providers of the reliability of devices post-launch but also supports continuous improvement efforts. By establishing strong feedback mechanisms, companies can swiftly adapt to real-world challenges and refine product design and functionality accordingly. Moreover, developing strategic partnerships with academic institutions and clinical research centers can further validate emerging technologies and enhance clinical credibility.

Adopting modular design strategies that allow for the rapid incorporation of new features is also recommended. This approach enables companies to be more agile in responding to market dynamics while ensuring that next-generation devices remain compatible with evolving clinical protocols. In parallel, market expansion strategies should be tailored to address regional nuances. For instance, customized approaches in regions with high regulatory stringency versus those with burgeoning healthcare infrastructure can significantly improve market penetration and consumer adoption rates.

Finally, fostering a culture of innovation within organizations, supported by ongoing professional development and cross-functional collaboration, is vital. Encouraging interdisciplinary exchanges between clinical experts, engineers, and data scientists fosters an environment where novel ideas can transform into viable product solutions. In doing so, companies position themselves to not only capture immediate market opportunities but also to sustain long-term growth in an increasingly competitive industry.

Recap and Forward Outlook on the Cardiovascular Devices Market

Reflecting upon the comprehensive analysis of the cardiovascular devices market, it becomes evident that the landscape is both complex and promising. The sector is defined by significant technological advancements and evolving business strategies that are collectively driving improvement in patient outcomes and operational tendencies. From the early detection and monitoring of cardiac anomalies to intricate surgical interventions and innovative therapeutic approaches, the market continues to adapt to a rapidly changing environment. The segmentation analysis has revealed vital insights into the nuances of device types, operational mechanisms, access pathways, clinical applications, and end-user environments. This systematic breakdown not only simplifies the market dynamics but also provides a clear pathway for targeted investments and innovation.

Moreover, the regional review has illustrated the diverse regulatory frameworks, healthcare spending habits, and adoption rates. Whether it is the mature technology markets in the Americas, the balanced approach in the Europe, Middle East & Africa region, or the rapidly expanding healthcare systems in Asia-Pacific, each territory presents unique advantages and challenges. Coupled with a competitive analysis of leading market players, the overall landscape is depicted as one of vigorous innovation tempered with strategic precision, paving the way for sustained growth and enhanced global reach.

As the market continues to evolve, stakeholders are called upon to adopt a multidimensional strategy that is equally sensitive to technological evolutions and market-specific demands. The forward outlook remains optimistic, with emerging trends and innovations expected to further redefine industry standards and open new opportunities for growth and partnership. This dynamic interplay of market forces positions the cardiovascular devices industry on a trajectory toward even greater clinical and commercial achievements.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing prevalence of cardiovascular diseases among population
      • 5.1.1.2. Expanding healthcare infrastructure across the globe
    • 5.1.2. Restraints
      • 5.1.2.1. Issues over cardiovascular devices recall incidences
    • 5.1.3. Opportunities
      • 5.1.3.1. Growing adoption of cardiovascular devices in home healthcare
      • 5.1.3.2. Government initiatives and funding in boosting the adoption of cardiovascular devices
    • 5.1.4. Challenges
      • 5.1.4.1. Stringent regulatory requirements for device approval processes
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Device Type: Burgeoning adoption of blood pressure monitors essential for diagnosing and managing hypertension
    • 5.2.2. End-User: Evolving utilization of cardiovascular devices across the ambulatory surgical centers
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Cardiovascular Devices Market, by Device Type

  • 6.1. Introduction
  • 6.2. Diagnostic & Monitoring Devices
    • 6.2.1. ECG Systems
    • 6.2.2. Electrode Leads & Accessories
    • 6.2.3. Event Monitors
    • 6.2.4. Holter Monitors
    • 6.2.5. Implantable Loop Recorders
  • 6.3. Surgical Devices
    • 6.3.1. Cardiac Stents
    • 6.3.2. Catheters
    • 6.3.3. Heart Valves
    • 6.3.4. Vascular Grafts
  • 6.4. Therapeutic Devices
    • 6.4.1. Blood Pressure Monitors
    • 6.4.2. Defibrillators
    • 6.4.3. Pacemakers

7. Cardiovascular Devices Market, by Operation Type

  • 7.1. Introduction
  • 7.2. Invasive Devices
  • 7.3. Non-Invasive Devices

8. Cardiovascular Devices Market, by Access Type

  • 8.1. Introduction
  • 8.2. Transcutaneous
  • 8.3. Transvenous

9. Cardiovascular Devices Market, by Application

  • 9.1. Introduction
  • 9.2. Cardiac Rhythm Management
  • 9.3. Coronary Artery Disease
  • 9.4. Peripheral Vascular Disease
  • 9.5. Stroke Management

10. Cardiovascular Devices Market, by End User

  • 10.1. Introduction
  • 10.2. Ambulatory Surgical Centers
  • 10.3. Home Care
  • 10.4. Hospitals & Clinics

11. Americas Cardiovascular Devices Market

  • 11.1. Introduction
  • 11.2. Argentina
  • 11.3. Brazil
  • 11.4. Canada
  • 11.5. Mexico
  • 11.6. United States

12. Asia-Pacific Cardiovascular Devices Market

  • 12.1. Introduction
  • 12.2. Australia
  • 12.3. China
  • 12.4. India
  • 12.5. Indonesia
  • 12.6. Japan
  • 12.7. Malaysia
  • 12.8. Philippines
  • 12.9. Singapore
  • 12.10. South Korea
  • 12.11. Taiwan
  • 12.12. Thailand
  • 12.13. Vietnam

13. Europe, Middle East & Africa Cardiovascular Devices Market

  • 13.1. Introduction
  • 13.2. Denmark
  • 13.3. Egypt
  • 13.4. Finland
  • 13.5. France
  • 13.6. Germany
  • 13.7. Israel
  • 13.8. Italy
  • 13.9. Netherlands
  • 13.10. Nigeria
  • 13.11. Norway
  • 13.12. Poland
  • 13.13. Qatar
  • 13.14. Russia
  • 13.15. Saudi Arabia
  • 13.16. South Africa
  • 13.17. Spain
  • 13.18. Sweden
  • 13.19. Switzerland
  • 13.20. Turkey
  • 13.21. United Arab Emirates
  • 13.22. United Kingdom

14. Competitive Landscape

  • 14.1. Market Share Analysis, 2024
  • 14.2. FPNV Positioning Matrix, 2024
  • 14.3. Competitive Scenario Analysis
    • 14.3.1. DocGo and SHL Telemedicine's SmartHeart Enhances Cardiac Care Nationwide
    • 14.3.2. Philips unveils AI-driven cardiology innovations at TCT 2024 to enhance patient care and clinical workflows
    • 14.3.3. Tentamus Group strengthens global foothold in cardiovascular devices with acquisition of CardioMed Consultants
  • 14.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Abbott Laboratories
  • 2. ACS Diagnostics
  • 3. Alivecor, Inc.
  • 4. Asahi Kasei Corporation
  • 5. B. Braun SE
  • 6. Baxter International Inc.
  • 7. Bexen Medical
  • 8. Biotronik SE & Co KG
  • 9. Boston Scientific Corporation
  • 10. BPL Medical Technologies Private Limited
  • 11. Edwards Lifesciences Corporation
  • 12. GE Healthcare
  • 13. HeartFlow Holding, Inc.
  • 14. Johnson & Johnson Services, Inc.
  • 15. Koninklijke Philips N.V.,
  • 16. Lepu Medical Technology(Beijing)Co.,Ltd.
  • 17. LivaNova PLC
  • 18. Medtronic PLC
  • 19. Microport Scientific Corporation
  • 20. Nihon Kohden Corporation
  • 21. Schiller AG
  • 22. Siemens Healthineers
  • 23. Terumo Cardiovascular Systems Corporation
  • 24. Tricog Health
  • 25. Vesalius Cardiovascular Inc.
  • 26. Zoll Medical Corporation

LIST OF FIGURES

  • FIGURE 1. CARDIOVASCULAR DEVICES MARKET MULTI-CURRENCY
  • FIGURE 2. CARDIOVASCULAR DEVICES MARKET MULTI-LANGUAGE
  • FIGURE 3. CARDIOVASCULAR DEVICES MARKET RESEARCH PROCESS
  • FIGURE 4. CARDIOVASCULAR DEVICES MARKET SIZE, 2024 VS 2030
  • FIGURE 5. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 6. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 7. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2024 VS 2030 (%)
  • FIGURE 9. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY OPERATION TYPE, 2024 VS 2030 (%)
  • FIGURE 11. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY OPERATION TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY ACCESS TYPE, 2024 VS 2030 (%)
  • FIGURE 13. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY ACCESS TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 14. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
  • FIGURE 15. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 16. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY END USER, 2024 VS 2030 (%)
  • FIGURE 17. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 18. AMERICAS CARDIOVASCULAR DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 19. AMERICAS CARDIOVASCULAR DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 20. UNITED STATES CARDIOVASCULAR DEVICES MARKET SIZE, BY STATE, 2024 VS 2030 (%)
  • FIGURE 21. UNITED STATES CARDIOVASCULAR DEVICES MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 22. ASIA-PACIFIC CARDIOVASCULAR DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 23. ASIA-PACIFIC CARDIOVASCULAR DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 24. EUROPE, MIDDLE EAST & AFRICA CARDIOVASCULAR DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 25. EUROPE, MIDDLE EAST & AFRICA CARDIOVASCULAR DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 26. CARDIOVASCULAR DEVICES MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 27. CARDIOVASCULAR DEVICES MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. CARDIOVASCULAR DEVICES MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. CARDIOVASCULAR DEVICES MARKET DYNAMICS
  • TABLE 7. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY ECG SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY ELECTRODE LEADS & ACCESSORIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY EVENT MONITORS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY HOLTER MONITORS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY IMPLANTABLE LOOP RECORDERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY SURGICAL DEVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY CARDIAC STENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY CATHETERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY HEART VALVES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY VASCULAR GRAFTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC DEVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY BLOOD PRESSURE MONITORS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY DEFIBRILLATORS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY PACEMAKERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC DEVICES, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY OPERATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY INVASIVE DEVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY NON-INVASIVE DEVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 29. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY ACCESS TYPE, 2018-2030 (USD MILLION)
  • TABLE 30. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY TRANSCUTANEOUS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 31. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY TRANSVENOUS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 32. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 33. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY CARDIAC RHYTHM MANAGEMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 34. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY CORONARY ARTERY DISEASE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 35. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY PERIPHERAL VASCULAR DISEASE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 36. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY STROKE MANAGEMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 37. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 38. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 39. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY HOME CARE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 40. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 41. AMERICAS CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 42. AMERICAS CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 43. AMERICAS CARDIOVASCULAR DEVICES MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 44. AMERICAS CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC DEVICES, 2018-2030 (USD MILLION)
  • TABLE 45. AMERICAS CARDIOVASCULAR DEVICES MARKET SIZE, BY OPERATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 46. AMERICAS CARDIOVASCULAR DEVICES MARKET SIZE, BY ACCESS TYPE, 2018-2030 (USD MILLION)
  • TABLE 47. AMERICAS CARDIOVASCULAR DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 48. AMERICAS CARDIOVASCULAR DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 49. AMERICAS CARDIOVASCULAR DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 50. ARGENTINA CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 51. ARGENTINA CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 52. ARGENTINA CARDIOVASCULAR DEVICES MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 53. ARGENTINA CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC DEVICES, 2018-2030 (USD MILLION)
  • TABLE 54. ARGENTINA CARDIOVASCULAR DEVICES MARKET SIZE, BY OPERATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 55. ARGENTINA CARDIOVASCULAR DEVICES MARKET SIZE, BY ACCESS TYPE, 2018-2030 (USD MILLION)
  • TABLE 56. ARGENTINA CARDIOVASCULAR DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 57. ARGENTINA CARDIOVASCULAR DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 58. BRAZIL CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 59. BRAZIL CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 60. BRAZIL CARDIOVASCULAR DEVICES MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 61. BRAZIL CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC DEVICES, 2018-2030 (USD MILLION)
  • TABLE 62. BRAZIL CARDIOVASCULAR DEVICES MARKET SIZE, BY OPERATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 63. BRAZIL CARDIOVASCULAR DEVICES MARKET SIZE, BY ACCESS TYPE, 2018-2030 (USD MILLION)
  • TABLE 64. BRAZIL CARDIOVASCULAR DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 65. BRAZIL CARDIOVASCULAR DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 66. CANADA CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 67. CANADA CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 68. CANADA CARDIOVASCULAR DEVICES MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 69. CANADA CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC DEVICES, 2018-2030 (USD MILLION)
  • TABLE 70. CANADA CARDIOVASCULAR DEVICES MARKET SIZE, BY OPERATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 71. CANADA CARDIOVASCULAR DEVICES MARKET SIZE, BY ACCESS TYPE, 2018-2030 (USD MILLION)
  • TABLE 72. CANADA CARDIOVASCULAR DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 73. CANADA CARDIOVASCULAR DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 74. MEXICO CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 75. MEXICO CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 76. MEXICO CARDIOVASCULAR DEVICES MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 77. MEXICO CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC DEVICES, 2018-2030 (USD MILLION)
  • TABLE 78. MEXICO CARDIOVASCULAR DEVICES MARKET SIZE, BY OPERATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 79. MEXICO CARDIOVASCULAR DEVICES MARKET SIZE, BY ACCESS TYPE, 2018-2030 (USD MILLION)
  • TABLE 80. MEXICO CARDIOVASCULAR DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 81. MEXICO CARDIOVASCULAR DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 82. UNITED STATES CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 83. UNITED STATES CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 84. UNITED STATES CARDIOVASCULAR DEVICES MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 85. UNITED STATES CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC DEVICES, 2018-2030 (USD MILLION)
  • TABLE 86. UNITED STATES CARDIOVASCULAR DEVICES MARKET SIZE, BY OPERATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 87. UNITED STATES CARDIOVASCULAR DEVICES MARKET SIZE, BY ACCESS TYPE, 2018-2030 (USD MILLION)
  • TABLE 88. UNITED STATES CARDIOVASCULAR DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 89. UNITED STATES CARDIOVASCULAR DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 90. UNITED STATES CARDIOVASCULAR DEVICES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 91. ASIA-PACIFIC CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 92. ASIA-PACIFIC CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 93. ASIA-PACIFIC CARDIOVASCULAR DEVICES MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 94. ASIA-PACIFIC CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC DEVICES, 2018-2030 (USD MILLION)
  • TABLE 95. ASIA-PACIFIC CARDIOVASCULAR DEVICES MARKET SIZE, BY OPERATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 96. ASIA-PACIFIC CARDIOVASCULAR DEVICES MARKET SIZE, BY ACCESS TYPE, 2018-2030 (USD MILLION)
  • TABLE 97. ASIA-PACIFIC CARDIOVASCULAR DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 98. ASIA-PACIFIC CARDIOVASCULAR DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 99. ASIA-PACIFIC CARDIOVASCULAR DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 100. AUSTRALIA CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 101. AUSTRALIA CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 102. AUSTRALIA CARDIOVASCULAR DEVICES MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 103. AUSTRALIA CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC DEVICES, 2018-2030 (USD MILLION)
  • TABLE 104. AUSTRALIA CARDIOVASCULAR DEVICES MARKET SIZE, BY OPERATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 105. AUSTRALIA CARDIOVASCULAR DEVICES MARKET SIZE, BY ACCESS TYPE, 2018-2030 (USD MILLION)
  • TABLE 106. AUSTRALIA CARDIOVASCULAR DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 107. AUSTRALIA CARDIOVASCULAR DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 108. CHINA CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 109. CHINA CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 110. CHINA CARDIOVASCULAR DEVICES MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 111. CHINA CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC DEVICES, 2018-2030 (USD MILLION)
  • TABLE 112. CHINA CARDIOVASCULAR DEVICES MARKET SIZE, BY OPERATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 113. CHINA CARDIOVASCULAR DEVICES MARKET SIZE, BY ACCESS TYPE, 2018-2030 (USD MILLION)
  • TABLE 114. CHINA CARDIOVASCULAR DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 115. CHINA CARDIOVASCULAR DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 116. INDIA CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 117. INDIA CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 118. INDIA CARDIOVASCULAR DEVICES MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 119. INDIA CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC DEVICES, 2018-2030 (USD MILLION)
  • TABLE 120. INDIA CARDIOVASCULAR DEVICES MARKET SIZE, BY OPERATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 121. INDIA CARDIOVASCULAR DEVICES MARKET SIZE, BY ACCESS TYPE, 2018-2030 (USD MILLION)
  • TABLE 122. INDIA CARDIOVASCULAR DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 123. INDIA CARDIOVASCULAR DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 124. INDONESIA CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 125. INDONESIA CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 126. INDONESIA CARDIOVASCULAR DEVICES MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 127. INDONESIA CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC DEVICES, 2018-2030 (USD MILLION)
  • TABLE 128. INDONESIA CARDIOVASCULAR DEVICES MARKET SIZE, BY OPERATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 129. INDONESIA CARDIOVASCULAR DEVICES MARKET SIZE, BY ACCESS TYPE, 2018-2030 (USD MILLION)
  • TABLE 130. INDONESIA CARDIOVASCULAR DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 131. INDONESIA CARDIOVASCULAR DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 132. JAPAN CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 133. JAPAN CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 134. JAPAN CARDIOVASCULAR DEVICES MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 135. JAPAN CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC DEVICES, 2018-2030 (USD MILLION)
  • TABLE 136. JAPAN CARDIOVASCULAR DEVICES MARKET SIZE, BY OPERATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 137. JAPAN CARDIOVASCULAR DEVICES MARKET SIZE, BY ACCESS TYPE, 2018-2030 (USD MILLION)
  • TABLE 138. JAPAN CARDIOVASCULAR DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 139. JAPAN CARDIOVASCULAR DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 140. MALAYSIA CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 141. MALAYSIA CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 142. MALAYSIA CARDIOVASCULAR DEVICES MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 143. MALAYSIA CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC DEVICES, 2018-2030 (USD MILLION)
  • TABLE 144. MALAYSIA CARDIOVASCULAR DEVICES MARKET SIZE, BY OPERATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 145. MALAYSIA CARDIOVASCULAR DEVICES MARKET SIZE, BY ACCESS TYPE, 2018-2030 (USD MILLION)
  • TABLE 146. MALAYSIA CARDIOVASCULAR DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 147. MALAYSIA CARDIOVASCULAR DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 148. PHILIPPINES CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 149. PHILIPPINES CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 150. PHILIPPINES CARDIOVASCULAR DEVICES MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 151. PHILIPPINES CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC DEVICES, 2018-2030 (USD MILLION)
  • TABLE 152. PHILIPPINES CARDIOVASCULAR DEVICES MARKET SIZE, BY OPERATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 153. PHILIPPINES CARDIOVASCULAR DEVICES MARKET SIZE, BY ACCESS TYPE, 2018-2030 (USD MILLION)
  • TABLE 154. PHILIPPINES CARDIOVASCULAR DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 155. PHILIPPINES CARDIOVASCULAR DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 156. SINGAPORE CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 157. SINGAPORE CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 158. SINGAPORE CARDIOVASCULAR DEVICES MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 159. SINGAPORE CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC DEVICES, 2018-2030 (USD MILLION)
  • TABLE 160. SINGAPORE CARDIOVASCULAR DEVICES MARKET SIZE, BY OPERATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 161. SINGAPORE CARDIOVASCULAR DEVICES MARKET SIZE, BY ACCESS TYPE, 2018-2030 (USD MILLION)
  • TABLE 162. SINGAPORE CARDIOVASCULAR DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 163. SINGAPORE CARDIOVASCULAR DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 164. SOUTH KOREA CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 165. SOUTH KOREA CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 166. SOUTH KOREA CARDIOVASCULAR DEVICES MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 167. SOUTH KOREA CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC DEVICES, 2018-2030 (USD MILLION)
  • TABLE 168. SOUTH KOREA CARDIOVASCULAR DEVICES MARKET SIZE, BY OPERATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 169. SOUTH KOREA CARDIOVASCULAR DEVICES MARKET SIZE, BY ACCESS TYPE, 2018-2030 (USD MILLION)
  • TABLE 170. SOUTH KOREA CARDIOVASCULAR DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 171. SOUTH KOREA CARDIOVASCULAR DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 172. TAIWAN CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 173. TAIWAN CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 174. TAIWAN CARDIOVASCULAR DEVICES MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 175. TAIWAN CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC DEVICES, 2018-2030 (USD MILLION)
  • TABLE 176. TAIWAN CARDIOVASCULAR DEVICES MARKET SIZE, BY OPERATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 177. TAIWAN CARDIOVASCULAR DEVICES MARKET SIZE, BY ACCESS TYPE, 2018-2030 (USD MILLION)
  • TABLE 178. TAIWAN CARDIOVASCULAR DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 179. TAIWAN CARDIOVASCULAR DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 180. THAILAND CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 181. THAILAND CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 182. THAILAND CARDIOVASCULAR DEVICES MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 183. THAILAND CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC DEVICES, 2018-2030 (USD MILLION)
  • TABLE 184. THAILAND CARDIOVASCULAR DEVICES MARKET SIZE, BY OPERATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 185. THAILAND CARDIOVASCULAR DEVICES MARKET SIZE, BY ACCESS TYPE, 2018-2030 (USD MILLION)
  • TABLE 186. THAILAND CARDIOVASCULAR DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 187. THAILAND CARDIOVASCULAR DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 188. VIETNAM CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 189. VIETNAM CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 190. VIETNAM CARDIOVASCULAR DEVICES MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 191. VIETNAM CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC DEVICES, 2018-2030 (USD MILLION)
  • TABLE 192. VIETNAM CARDIOVASCULAR DEVICES MARKET SIZE, BY OPERATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 193. VIETNAM CARDIOVASCULAR DEVICES MARKET SIZE, BY ACCESS TYPE, 2018-2030 (USD MILLION)
  • TABLE 194. VIETNAM CARDIOVASCULAR DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 195. VIETNAM CARDIOVASCULAR DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 196. EUROPE, MIDDLE EAST & AFRICA CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 197. EUROPE, MIDDLE EAST & AFRICA CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 198. EUROPE, MIDDLE EAST & AFRICA CARDIOVASCULAR DEVICES MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 199. EUROPE, MIDDLE EAST & AFRICA CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC DEVICES, 2018-2030 (USD MILLION)
  • TABLE 200. EUROPE, MIDDLE EAST & AFRICA CARDIOVASCULAR DEVICES MARKET SIZE, BY OPERATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 201. EUROPE, MIDDLE EAST & AFRICA CARDIOVASCULAR DEVICES MARKET SIZE, BY ACCESS TYPE, 2018-2030 (USD MILLION)
  • TABLE 202. EUROPE, MIDDLE EAST & AFRICA CARDIOVASCULAR DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 203. EUROPE, MIDDLE EAST & AFRICA CARDIOVASCULAR DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 204. EUROPE, MIDDLE EAST & AFRICA CARDIOVASCULAR DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 205. DENMARK CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 206. DENMARK CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 207. DENMARK CARDIOVASCULAR DEVICES MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 208. DENMARK CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC DEVICES, 2018-2030 (USD MILLION)
  • TABLE 209. DENMARK CARDIOVASCULAR DEVICES MARKET SIZE, BY OPERATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 210. DENMARK CARDIOVASCULAR DEVICES MARKET SIZE, BY ACCESS TYPE, 2018-2030 (USD MILLION)
  • TABLE 211. DENMARK CARDIOVASCULAR DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 212. DENMARK CARDIOVASCULAR DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 213. EGYPT CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 214. EGYPT CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 215. EGYPT CARDIOVASCULAR DEVICES MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 216. EGYPT CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC DEVICES, 2018-2030 (USD MILLION)
  • TABLE 217. EGYPT CARDIOVASCULAR DEVICES MARKET SIZE, BY OPERATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 218. EGYPT CARDIOVASCULAR DEVICES MARKET SIZE, BY ACCESS TYPE, 2018-2030 (USD MILLION)
  • TABLE 219. EGYPT CARDIOVASCULAR DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 220. EGYPT CARDIOVASCULAR DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 221. FINLAND CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 222. FINLAND CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 223. FINLAND CARDIOVASCULAR DEVICES MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 224. FINLAND CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC DEVICES, 2018-2030 (USD MILLION)
  • TABLE 225. FINLAND CARDIOVASCULAR DEVICES MARKET SIZE, BY OPERATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 226. FINLAND CARDIOVASCULAR DEVICES MARKET SIZE, BY ACCESS TYPE, 2018-2030 (USD MILLION)
  • TABLE 227. FINLAND CARDIOVASCULAR DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 228. FINLAND CARDIOVASCULAR DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 229. FRANCE CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 230. FRANCE CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 231. FRANCE CARDIOVASCULAR DEVICES MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 232. FRANCE CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC DEVICES, 2018-2030 (USD MILLION)
  • TABLE 233. FRANCE CARDIOVASCULAR DEVICES MARKET SIZE, BY OPERATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 234. FRANCE CARDIOVASCULAR DEVICES MARKET SIZE, BY ACCESS TYPE, 2018-2030 (USD MILLION)
  • TABLE 235. FRANCE CARDIOVASCULAR DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 236. FRANCE CARDIOVASCULAR DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 237. GERMANY CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 238. GERMANY CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 239. GERMANY CARDIOVASCULAR DEVICES MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 240. GERMANY CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC DEVICES, 2018-2030 (USD MILLION)
  • TABLE 241. GERMANY CARDIOVASCULAR DEVICES MARKET SIZE, BY OPERATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 242. GERMANY CARDIOVASCULAR DEVICES MARKET SIZE, BY ACCESS TYPE, 2018-2030 (USD MILLION)
  • TABLE 243. GERMANY CARDIOVASCULAR DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 244. GERMANY CARDIOVASCULAR DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 245. ISRAEL CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 246. ISRAEL CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 247. ISRAEL CARDIOVASCULAR DEVICES MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 248. ISRAEL CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC DEVICES, 2018-2030 (USD MILLION)
  • TABLE 249. ISRAEL CARDIOVASCULAR DEVICES MARKET SIZE, BY OPERATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 250. ISRAEL CARDIOVASCULAR DEVICES MARKET SIZE, BY ACCESS TYPE, 2018-2030 (USD MILLION)
  • TABLE 251. ISRAEL CARDIOVASCULAR DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 252. ISRAEL CARDIOVASCULAR DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 253. ITALY CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 254. ITALY CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 255. ITALY CARDIOVASCULAR DEVICES MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 256. ITALY CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC DEVICES, 2018-2030 (USD MILLION)
  • TABLE 257. ITALY CARDIOVASCULAR DEVICES MARKET SIZE, BY OPERATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 258. ITALY CARDIOVASCULAR DEVICES MARKET SIZE, BY ACCESS TYPE, 2018-2030 (USD MILLION)
  • TABLE 259. ITALY CARDIOVASCULAR DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 260. ITALY CARDIOVASCULAR DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 261. NETHERLANDS CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 262. NETHERLANDS CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 263. NETHERLANDS CARDIOVASCULAR DEVICES MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 264. NETHERLANDS CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC DEVICES, 2018-2030 (USD MILLION)
  • TABLE 265. NETHERLANDS CARDIOVASCULAR DEVICES MARKET SIZE, BY OPERATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 266. NETHERLANDS CARDIOVASCULAR DEVICES MARKET SIZE, BY ACCESS TYPE, 2018-2030 (USD MILLION)
  • TABLE 267. NETHERLANDS CARDIOVASCULAR DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 268. NETHERLANDS CARDIOVASCULAR DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 269. NIGERIA CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 270. NIGERIA CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 271. NIGERIA CARDIOVASCULAR DEVICES MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 272. NIGERIA CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC DEVICES, 2018-2030 (USD MILLION)
  • TABLE 273. NIGERIA CARDIOVASCULAR DEVICES MARKET SIZE, BY OPERATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 274. NIGERIA CARDIOVASCULAR DEVICES MARKET SIZE, BY ACCESS TYPE, 2018-2030 (USD MILLION)
  • TABLE 275. NIGERIA CARDIOVASCULAR DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 276. NIGERIA CARDIOVASCULAR DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 277. NORWAY CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 278. NORWAY CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 279. NORWAY CARDIOVASCULAR DEVICES MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 280. NORWAY CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC DEVICES, 2018-2030 (USD MILLION)
  • TABLE 281. NORWAY CARDIOVASCULAR DEVICES MARKET SIZE, BY OPERATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 282. NORWAY CARDIOVASCULAR DEVICES MARKET SIZE, BY ACCESS TYPE, 2018-2030 (USD MILLION)
  • TABLE 283. NORWAY CARDIOVASCULAR DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 284. NORWAY CARDIOVASCULAR DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 285. POLAND CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 286. POLAND CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 287. POLAND CARDIOVASCULAR DEVICES MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 288. POLAND CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC DEVICES, 2018-2030 (USD MILLION)
  • TABLE 289. POLAND CARDIOVASCULAR DEVICES MARKET SIZE, BY OPERATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 290. POLAND CARDIOVASCULAR DEVICES MARKET SIZE, BY ACCESS TYPE, 2018-2030 (USD MILLION)
  • TABLE 291. POLAND CARDIOVASCULAR DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 292. POLAND CARDIOVASCULAR DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 293. QATAR CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 294. QATAR CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 295. QATAR CARDIOVASCULAR DEVICES MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 296. QATAR CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC DEVICES, 2018-2030 (USD MILLION)
  • TABLE 297. QATAR CARDIOVASCULAR DEVICES MARKET SIZE, BY OPERATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 298. QATAR CARDIOVASCULAR DEVICES MARKET SIZE, BY ACCESS TYPE, 2018-2030 (USD MILLION)
  • TABLE 299. QATAR CARDIOVASCULAR DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 300. QATAR CARDIOVASCULAR DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 301. RUSSIA CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 302. RUSSIA CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 303. RUSSIA CARDIOVASCULAR DEVICES MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 304. RUSSIA CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC DEVICES, 2018-2030 (USD MILLION)
  • TABLE 305. RUSSIA CARDIOVASCULAR DEVICES MARKET SIZE, BY OPERATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 306. RUSSIA CARDIOVASCULAR DEVICES MARKET SIZE, BY ACCESS TYPE, 2018-2030 (USD MILLION)
  • TABLE 307. RUSSIA CARDIOVASCULAR DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 308. RUSSIA CARDIOVASCULAR DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 309. SAUDI ARABIA CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 310. SAUDI ARABIA CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 311. SAUDI ARABIA CARDIOVASCULAR DEVICES MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 312. SAUDI ARABIA CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC DEVICES, 2018-2030 (USD MILLION)
  • TABLE 313. SAUDI ARABIA CARDIOVASCULAR DEVICES MARKET SIZE, BY OPERATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 314. SAUDI ARABIA CARDIOVASCULAR DEVICES MARKET SIZE, BY ACCESS TYPE, 2018-2030 (USD MILLION)
  • TABLE 315. SAUDI ARABIA CARDIOVASCULAR DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 316. SAUDI ARABIA CARDIOVASCULAR DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 317. SOUTH AFRICA CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 318. SOUTH AFRICA CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 319. SOUTH AFRICA CARDIOVASCULAR DEVICES MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 320. SOUTH AFRICA CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC DEVICES, 2018-2030 (USD MILLION)
  • TABLE 321. SOUTH AFRICA CARDIOVASCULAR DEVICES MARKET SIZE, BY OPERATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 322. SOUTH AFRICA CARDIOVASCULAR DEVICES MARKET SIZE, BY ACCESS TYPE, 2018-2030 (USD MILLION)
  • TABLE 323. SOUTH AFRICA CARDIOVASCULAR DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 324. SOUTH AFRICA CARDIOVASCULAR DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 325. SPAIN CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 326. SPAIN CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 327. SPAIN CARDIOVASCULAR DEVICES M